Reuters Health - The genes we inherit from our parents are thought to
influence how we act, but documenting a direct effect of genes on behavior has
been difficult. Now, scientists have found that people who carry a particular
genetic variation experience greater activity in a fear-related brain region
when shown pictures of frightened or angry faces.
"This is the first study to show a genetic effect on a system in the brain
related to human emotions," the study's lead author, Dr. Daniel R. Weinberger of
the National Institute of Mental Health in Bethesda, Maryland, told Reuters
Health.
He noted that scientists "have known for a long time that temperament is
genetic and that it is present to some degree from very early in life." It has
also been known that the amygdala--the brain region monitored in the study--is
involved in emotions, especially danger-related fear and anxiety, he explained.
Anxiety varies widely from person to person, and some research has suggested
that anxiety-related behavior may be influenced by a variation in a gene for a
protein involved in moving the chemical serotonin around the brain. This
serotonin transporter gene comes in long and short versions, and having at least
one of the short versions, which leads to less efficient transporting of
serotonin, has been tentatively linked to increased anxiety.
To test the connection between the short version of the serotonin transporter
gene and anxiety, Weinberger and his colleagues screened 28 volunteers for the
variations. Half of the participants had two copies of the long version-one
inherited from each parent--while the others had at least one short copy.
The participants were presented with pictures of frightened or angry faces.
They had to match the photos to other faces showing the same emotion. During the
exercise, the researchers monitored the activity in the amygdala.
People with at least one short version of the gene exhibited greater activity
in the amygdala than people with two long copies, the researchers report in the
July 19th issue of the journal Science.
"This study shows that one of the factors related to the response of the
amygdala to the environment, presumably how quick it is to see dangerousness, is
related to the form of the gene that people inherit," Weinberger said.
"It is the first time we have been able to see how a gene contributes to
aspects of human emotionality and temperament," he said.
Weinberger cautioned, however, "It is important to note that there is a lot
more to fear and anxiety than this gene, but it appears to be one of the
factors." Now that this factor has been identified, it may be easier to figure
out the other influences, he said. The next step, according to Weinberger, is to
explore other genes and environmental factors that interact with the gene and
the amygdala's response to the environment.
SOURCE: Science 2002;297:400-403.
* * *
Researchers Develop Mouse Model Of Rett Syndrome
Studies might improve understanding of leading cause of mental retardation in
girls
By studying gene mutations in patients with the complex set of behavioral and
neurological symptoms that accompany Rett syndrome, Howard Hughes Medical
Institute investigator Huda Zoghbi and her colleagues at Baylor College of
Medicine have designed a mouse model that faithfully recapitulates the disease
down to its distinctive hand-wringing behavior.
The development of the mouse, reported in the July 18, 2002 issue of the
journal Neuron, provides a springboard into the study of Rett syndrome, the
leading cause of mental retardation in girls.
First recognized as a syndrome in the 1980s, the disorder affects one in
10,000-15,000 girls. It is particularly devastating for families with affected
children because infants are seemingly normal at birth and achieve the usual
developmental milestones for the first few months of life. Then, as the infant
reaches toddlerhood, a sudden and dramatic decline in physical and mental
capabilities takes hold, accompanied by onset of seizures, irregular breathing,
awkward gait, and hand-wringing.
"I know of no other neurological disease that gives this distinctive
stereotypic behavior -- this hand-wringing these girls do basically all the time
they are awake," said Zoghbi. "With this mouse model we can now ask, 'Why is
that?'"
Zoghbi has been studying Rett syndrome since the mid-1980s, when she first
encountered patients with the disorder as a neurology fellow and decided to
search for the gene responsible for the disorder. She reasoned that the gene
must be on the X chromosome, the female sex chromosome, and it must also be
essential because there had been no males reported to have the syndrome. (Since
males have only one X chromosome, mutations that knock out the gene's function
could be lethal at an embryonic stage.) In females, there are two copies of the
X chromosome, but in each cell only one of the two X chromosomes is active. The
scientists reasoned that if enough cells are "normal," they can compensate for
the mutated gene.
After 14 years of searching, a scientist in Zoghbi's lab found that a gene
called MECP2 was mutated in the Rett Syndrome patients they studied. Earlier
research suggested that the MeCP2 protein was responsible for making sure that
genes the cell has marked with a molecular tag, called a methyl group, are
silenced. The MeCP2 protein latches on to these methyl groups and prevents them
from being translated into protein.
How MeCP2's molecular role translates into a neurological disorder is still
not clear. Ever since a diagnostic test for the gene mutation was developed,
however, there has been a flood of new information about the prevalence of the
disorder. This information reveals that mutations in the MECP2 gene can take a
wide variety of forms.
"We now know of cases of classic autism and schizophrenia that are caused by
mutations in this gene," said Zoghbi. "The clinical spectrum is so broad that we
don't know the true prevalence of this mutation." She estimates that the
mutation may be twice as common as is currently thought, with perhaps one in
10,000 children affected.
What is clear so far is that the MECP2 gene, which resides at the end of the
long arm of the human and mouse X chromosome, plays a vital role in fine-tuning
the developing nervous system during a crucial stage when infants are learning
to sit up, walk, and begin language acquisition, said Zoghbi.
To understand the molecular details of what goes wrong, the scientists first
needed to create a mouse model of the disorder. The first attempt at a mouse
model, in which the MECP2 gene was deleted completely, resulted in severe
disease and early death. Zoghbi and her colleagues sought to create a model that
would more closely mimic the progression of the human disorder. So, they studied
the various mutations that had been found in patients to design a mutant mouse
that would produce a partially functional protein. The result was a mouse that
mimics many of the aspects of the disease observed in humans.
Using the mouse model, the scientists will probe how the MeCP2 protein
affects brain function at a crucial developmental stage. "The second part of the
story is really in discovering what this protein is doing in the brain," said
Zoghbi. "It may be that at a certain developmental stage, the brain suddenly
requires the function of this protein. In humans, by birth a lot of the
hardwiring has already happened. Infancy is a critical time as life experiences
refine synaptic function and strengthen synapses. Experiences fine tune the
brain. Perhaps more complex tasks require the input of this protein and its loss
is now instrumental. Things fall apart and people regress. Perhaps key genes
that are important at certain times are not put in place. We don't know the
mechanism but having this mouse model will allow us to ask these questions."
Zoghbi is hopeful that studying the mouse model will also have implications
for treatment of patients diagnosed with Rett Syndrome.
"As development progresses, what we encounter -- our experiences -- may also
change how the brain responds. This may account for individual variation in
disease severity," she said. "It may be that enrichment of the environment or
exposure to certain stimuli may give affected children more milestones. I could
envision that with interventional studies in mice, we may identify pathways that
could lead to behavioral or pharmacological approaches that may provide at least
symptomatic relief."
Beginning with cultured mouse embryonic stem cells, researchers have
administered a precise mix of chemical signals to coax the cells to
differentiate into functioning motor neurons.
The achievement was made possible by a decade of work in deciphering the
signals that trigger differentiation of motor neurons, which are responsible for
controlling the movement of muscles. The experiments represent an important step
in applying that knowledge to grow functioning neurons from stem cells -
undifferentiated cells that have the potential to become many different types of
adult cells.
According to the researchers, the success of the experiments with mouse cells
suggests that the same type of approach might be used to grow human motor
neurons from stem cells. Such neurons could enable regeneration of nerve tissue
lost to disease or trauma.
The experiments by researchers led by Howard Hughes Medical Institute
investigator Thomas Jessell at Columbia University were reported in an article
that was given immediate early publication status by the journal Cell and
published online on July 17, 2002. The research was funded in part by Project
A.L.S.
For more than 15 years, Jessell and his colleagues have been attempting to
untangle the delicate connections of nerve cells in the developing spinal cord.
Their studies have shown that the fledgling vertebrate nervous system is
crackling with activity - genes are being turned on and off at a rapid pace,
transforming immature cells into a billions-strong network of specialized neural
cells. Ultimately, Jessell hopes that his research will provide a more thorough
understanding of how the central nervous system (CNS) is constructed - this, he
says, may suggest new ways to repair diseased or damaged components of the
mature CNS.
According to Jessell, the attempt to generate motor neurons from stem cells
relied on many years of research to identify the chemical cues in the developing
embryo that coax "naive neuroprogenitor" cells to differentiate into spinal cord
motor neurons. These chemical signals "direct" ES cells down a developmental
pathway in successive stages -first into neurons and ultimately into ever more
specialized spinal cord motor neurons. Two of the key signals, said Jessell, are
retinoic acid, which converts mid-brain neural cells into spinal cord
progenitors, and Sonic hedgehog, a protein that converts spinal cord progenitor
cells into motor neurons.
"Until now, we have been trying to piece together these steps as individual
bites," said Jessell. "But we hadn't shown that the normal signaling factors
could be used conjointly to take a naive class of progenitors like ES cells, and
by sequential exposure to these factors, recapitulate this developmental
pathway."
First author Hynek Wichterle, a postdoctoral fellow in Jessell's laboratory,
began by using retinoic acid and other chemical cues to induce ES cells to
differentiate into mid-brain-type neurons and then into spinal cord neurons. The
scientists could follow the steps of differentiation by looking for the
expression of specific transcription factors that define the identity of cells
as spinal cord progenitor cells.
"Retinoids will give you spinal cord identity, but that doesn't determine
exactly which type of neuron emerges from these spinal cord progenitor cells,"
said Jessell. "And that's where Sonic hedgehog becomes important, because our
work and that of others had shown that you need Sonic hedgehog signaling at
exactly the right level of signal activation to generate motor neurons."
Thus, when the scientists exposed the cultured spinal cord neurons to
appropriate levels of the Sonic hedgehog protein, the cells differentiated to
become motor neurons. The dependence of this differentiation on a narrow
concentration range of the Sonic hedgehog protein is significant, said Jessell,
because in developing embryos the amount of Sonic hedgehog governs what type of
neuron will be generated.
In additional experiments, the scientists used ES cells from transgenic mice
whose motor neurons were tagged with a fluorescent marker. The fluorescent
tagging enabled Jessell and his colleagues to monitor, isolate and purify the
specific motor neurons they had induced - a technique that Jessell believes will
be crucial to further attempts to define the signaling pathways involved in
neuronal differentiation.
The researchers were also able to address an important question, namely,
whether the motor neurons they had developed in culture could actually function
in living animals. "We needed to demonstrate how well these in vitro-generated
motor neurons did when they were put into a living embryo," Jessell said. "So,
Hynek managed the very impressive technical feat of reintroducing these
ES-cell-derived motor neurons back into the spinal cords of chick embryos at a
stage when normal motor neurons are being generated." The scientists then tested
in the chick embryos how well the introduced neurons survived, integrated
themselves into the embryonic spinal cord and extended their long cable-like
axons toward their normal targets in muscle.
"I think our results documented that these ES-cell-derived motor neurons do a
pretty good job of mimicking their embryo-derived counterparts in all of those
three tests," said Jessell. "In general, I was pleasantly surprised by how well
neuralized ES cells recapitulate the developmental events that we have come to
associate with motor neuron progenitors and motor neurons."
Jessell believes that these successes represent only the beginning of a
promising line of research. "This is just the starting point for trying to take
a rational approach to studying the ability of ES-cell-derived motor neurons to
restore function, not just in an embryonic context, but in a more relevant adult
context," he said.
Jessell and his colleagues hope to use ES-generated motor neurons in
experiments to identify all the genes that govern the pathways of motor neuron
differentiation. They are also developing collaborations with neurologists to
explore in mouse models whether their motor neurons can regenerate spinal cords
that have been damaged by trauma or neurodegenerative diseases, such as
amyotrophic lateral sclerosis.
The researchers also plan to explore whether the signaling pathways of motor
neuron differentiation mice resemble those in humans. "I think one can be
cautiously optimistic that such parallels will exist," said Jessell. "While many
scientists have shown that human ES cells can give rise to neurons, we don't
know exactly which type of neurons they are. And, there's a much greater
heterogeneity in the properties of human ES cells than in mouse ES cells; so it
may be necessary to sift through a number of the available human ES cell lines
before arriving at a cell which behaves as its mouse counterpart. But, in
principle there is no reason why this type of approach might not be successful
with human cells," he said.
Scientists have succeeded in making brainier mice. Whether the animals were
actually smarter remains unknown, but their cerebral cortex surface area was
significantly larger than that of normal mice. The findings, published today in
the journal Science, may help explain how human brains came to be
disproportionately large compared to those of other species.
As the largest structure in the brain, the cerebral cortex harbors two-thirds
of the brain's neurons in a thin layer. In humans the cortex folds in on itself
in order to fit inside the skull, giving the brain a unique, wrinkled
topography. To investigate what controls the surface area of the cerebral
cortex, Anjen Chenn, now at Northwestern University School of Medicine, and
Christopher A. Walsh of Beth Israel Deaconess Medical Center developed a line of
transgenic mice. The animals carried a variant of a gene that makes a protein
thought to play a role in regulating cell growth in the developing brain. "We
found that in mice that overproduced the beta-catenin protein the mouse's
cerebral cortex grew dramatically so that instead of a flat sheet, it folded in
on itself and appeared 'wrinkled' much like it is in humans," Walsh explains.
(The image to the right shows the brains of a control mouse (top) and a
transgenic mouse (bottom).)
Specifically, beta-catenin was more abundant in precursor cells that become
neurons. The researchers propose that the protein may act as a switch that tells
the cells to keep dividing or to stop and become neurons. By causing more cell
division, excess beta-catenin creates a larger cortex with a greater number of
neurons. Further research is required to fully elucidate the role of beta-catenin,
including studies of whether its production is aberrant in cases of mental
retardation characterized by abnormally small brains. --Sarah Graham
When the video store doesn't have a movie or he doesn't like a math problem,
Logan Reilly screams -- loud, long, extreme screams that draw stares in public.
Logan, 13, can't control the outbursts. They're caused by autism, a
disability that affects the development of the brain in the areas of social
interaction and communication skills.
"I've resigned myself that there isn't anything that will take it away," said
his mother, Edys Reilly. "This is the way it is."
Nationwide, the number of children with autism has grown 10 percent to 17
percent a year during the past decade, according to the Centers for Disease
Control and Prevention. From 500,000 to 1.5 million people are believed to have
the condition, many of them children.
In Indiana, the number of children with autism registered in schools has
grown from 116 in 1989 to 3,832 last year, according to the state Department of
Education.
Some of the increase can be attributed to the broadening of diagnostic
criteria. But experts say that alone can't account for what's becoming a major
health crisis.
"We don't know the reasons for it, and we don't know the causes for it. But
we do know it's growing at an alarming rate," said Robert L. Beck, executive
director of the Autism Society of America.
Sharing ideas on how to tackle the epidemic will be the goal when about 1,750
people -- from parents to teachers to the world's leading experts on autism --
gather in Indianapolis today for the society's four-day annual conference.
"This is an opportunity for people to hear a diverse range of opinions," said
Dr. Cathy Pratt, director of the Indiana Resource Center for Autism. "If we're
to move forward as a community, we have to embrace those diverse opinions. We
have to realize there may be multiple paths, multiple reasons, multiple causes."
Ten years ago, autism was thought to be a rare disorder affecting 1 in 10,000
people. It is now estimated to affect 1 in 250.
The disability can manifest itself in different ways. In some mild cases,
such as Asperger's syndrome, the individual has social impairment but can have
above-average intelligence; severe cases can include self-destructive behavior
and an inability to communicate verbally.
Symptoms usually appear during a child's first three years. Children often
lag in speech development, avoid social interaction and eye contact and, in some
cases, throw tantrums for no apparent reason.
Researchers have found no cause and no cure. Many think the condition is
genetic; others believe it is caused by childhood vaccines, though no link has
been scientifically proven.
While the search for a cause continues, costs are mounting. Annually, about
$20 billion is spent on health, education and other services for people with
autism, Beck said.
Early intervention, such as speech and developmental therapies, can help
reduce that cost and improve the quality of life for children with autism, he
said.
Indiana hasn't increased funding for early intervention programs since the
mid-1990s, Pratt said. And while the number of children with autism has risen,
quality day care for children and adults is still scarce, she said.
But in some ways, Indiana is ahead of the nation. The state has provided
money for teacher training, Pratt said, and it offers something many states
don't: an autism waiver, funded through Medicaid, that pays for long-term care
and therapy.
Still, the waiting list is about 1,800 families long.
"What's happened is that the increase has happened so quickly, it caught most
every state off balance," Pratt said.
Amy and Steele Gudal of Carmel know how important those services are. Within
months, they learned that their two daughters -- 6-year-old Gentry and
7-year-old Gabrielle -- had autism. "I was numb," Amy Gudal said. "That allowed
me to just dive into the treatments and therapies."
Four years later, the Gudals want to help others. They hope to open a school
for children with autism to provide one-on-one instruction.
In the meantime, Amy Gudal said, her daughters teach her more than she
teaches them.
Tuesday morning, Gudal had a long list of things to do. But when Gentry
wanted her to come lie in bed, Gudal dropped her list and headed for the top
bunk.
"They're just who they are -- they love unconditionally," she said. "Instead
of getting frustrated, you just have to stop and say, 'What can I learn from
this?' "
* * *
Boston Area Schools Awarded Autism Awareness Grants
After her daughter was diagnosed with autism, Cathy Pitts learned quickly
that it takes more than parents to raise an autistic child. "The educational
support is just as important," said Pitts, of Brockton. "Teachers and
administrators in schools have to be aware of what children with autism need."
That task will be made easier in two local school districts by federal
autism-awareness grants announced last week. The Brockton and Old Rochester
Regional school districts will each receive $75,000 to aid autism instruction
and awareness.
Special education officials in both districts say they will use the money to
hire an autism specialist and to develop professional training for teachers
around Autism Spectrum Disorders, or ASD. According to the US Department of
Health and Human Services, as many as one in 500 children has been diagnosed
with some type of ASD, and the number is growing.
A developmental disability typically diagnosed within the first three years
of a child's life, autism affects the normal development of the brain in the
areas of social interaction and communication skills. In Massachusetts, there
are 3,451 students with autism, according to the Department of Education.
Terri Hamm, director of special education for the Old Rochester Regional
schools, said the 2,731-student district, which includes Marion, Mattapoisett,
and Rochester, has seen a steady increase in the number of autistic students.
She said the majority of the 26 students diagnosed with some type of ASD are
placed in general education classes, requiring specialized teacher training, and
special education support.
"It has been difficult on our staff because there are social issues, learning
needs, and behavioral concerns," Hamm said. "We're thrilled the grant was funded
because we're going to be able to develop social skills curriculum and help
classroom teachers and special ed. teachers in all our schools improve
instruction for kids with autism."
In the larger Brockton district, where about 70 students have been diagnosed
with ASD, some schools have classrooms designated for autistic students,
according to Joanne Malonson, director of special education services. But
because of the wide spectrum of autism disorders, other students are placed in
inclusion classrooms (a mix of general education students and students with
disabilities) or in general education classes with support such as one-on-one
assistance.
"Some of these kids are able to really achieve academically, but they're
lacking in social skills, communication, adaptive daily living skills and the
ability to manipulate life outside school community, like [to] order off a
restaurant menu, handle money, or choose their own clothes," Malonson said.
"They're not as successful in establishing relationships so we have to focus on
a mix of academic and communication skills."
She said the autism grant, one of 26 approved by the state Department of
Education last month, also will help the district provide more education on
autism for parents. Pitts, the Brockton parent, said she hopes the autism
specialist, who administrators hope to hire by the fall, will work to increase
collaboration between educators and the parents of autistic students. She said
her 12-year-old daughter, who attends Plouffe Elementary School, has benefited
already from a one-on-one teaching assistant.
But as more children are diagnosed, schools will need to be even more
prepared, Malonson said.
"Beyond early intervention, there hasn't been much done about what to do as
these students get older," she said. "We need to develop more programs like
vocational training to ensure their success."
c Copyright 2002 Globe Newspaper Company.
* * *
ADVOCACY
Special Ed Tax Could Spare Detroit Area Programs: Wayne County Proposal K
[Nickname it "Special K"?] 1.5 mills would help relieve tight budgets
[By Melanie D. Scott And Chastity Pratt in the Detroit Free Press.]
Richard Ham-Kucharski constantly thinks about the future of his 4-year-old
autistic son, Alex, which is why he has been working since May to get Proposal K
passed.
The Wayne County Regional Educational Service Agency announced earlier this
year that it would ask county voters to approve a 1.5-mill tax for special
education, and parents like Ham-Kucharski with special needs children began
educating others about the proposal.
"Special education students will not be the only ones to benefit," said Ham-Kucharski
of Canton, who has worked with the University of Michigan to develop special
education programs since 1998.
"This would put more money back into the school districts' general fund and
it would prevent program cuts for regular education students."
Under Proposal K, Wayne County RESA hopes to raise about $59 million annually
for special education programs. Local districts support the proposal because
administrators say it will allow them to avoid cuts to programs such as music
and art.
The 1.5-mill levy would raise taxes about $150 a year for owners of homes
valued at $200,000.
The idea for Proposal K was considered a year ago after district
superintendents agreed to support a millage, said Kathryn Mathey, executive
director of special education services for Wayne RESA.
"Rising special education costs are taking more and more out of local
districts' general education funds for state-mandated programs," said Mathey.
"Many districts are forced to cut back on prevention programs, which causes more
students to be referred to special education."
Detroit Public Schools has the most at stake: Of the 8,000 severely impaired
students in Wayne County, half are Detroit residents, said Aleatha Kimbrough,
executive director of student support programs for the school system.
Detroit schools will save millions of dollars if the millage passes,
according to the district's finance office. Last school year, the district spent
$14 million on programs for severely handicapped students. That figure is
expected to rise to $17 million in 2002-03.
"This is critical for all the children in Detroit," Kimbrough said. "We need
to support every revenue source we can for Detroit Public Schools. . . . If we
don't have the millage, the district still has to pay for it. That means less
money for children in general education."
Livonia Public Schools, the second-largest district in the county, is
expected to save $1.5 million annually if the millage passes.
The proposal has the support of several organizations, including the Citizens
Alliance to Uphold Special Education, known as CAUSE, and the Wayne County
Citizens Committee.
Opponents feel the proposal comes at the wrong time.
"This is not the time to raise taxes, and I don't think the existing system
needs to be fixed," said Roy Maybern of Dearborn Heights.
Wayne County voters will decide on Proposal K on Aug. 6.
UK Prime Minister Tony Blair has insisted there is not a "scrap of evidence
anywhere" to suggest the MMR vaccine should not be used.
He has also told the Commons the controversial triple vaccine should be
retained in its present form to provide the necessary "coverage".
Tory former minister Sir Sydney Chapman invited the Prime Minister to
distance himself from Mayor Ken Livingstone's advice to London parents not to
use the vaccine.
He warned take-up in the capital had reached a "record low" - only 70% of
parents in his constituency had sanctioned it for their children.
"The number of cases of measles in our capital city has quadrupled over the
past year," Sir Sydney said.
"As these two events are not unconnected will you take this opportunity of
publicly dissociating yourself from the remarks of the Mayor of London who is
advising London parents not to give children the jab?"
Mr Blair said: "I don't agree obviously with what was said by the Mayor,"
adding: "What should be made very, very clear is this: there is not a shred of
evidence anywhere that the MMR jab is anything but the right course to take.
"It is employed in 90 countries round the world, in America, Europe,
everywhere. It is absolutely essential that we retain it and retain it indeed in
its present form since that is the best way to get the coverage necessary to
deal with these diseases."
Many parents have refused to let their children have the jab because of an
alleged link to autism.
PRNewswire - Doctors and researchers on thecutting edge of medical research
are bringing hope to many of the 500,000children in the U.S. diagnosed with
autism and many of the more than2.5 million with attention deficit disorder
(ADD), attentiondeficit/hyperactivity disorder (ADHD) or chronic fatigue
syndrome (CFS).By treating these and other diseases as neuro-immune dysfunction
syndromes(NIDS) and viewing them as medical rather than developmental
disorders,Michael Goldberg, M.D., F.A.A.P, and his colleagues at the Neuro-Immune
Dysfunction Syndromes Research Institute
(NIDS-RI) have seen dramaticimprovement and normalization in children
previously deemed medicallyuntreatable.Autism is more prevalent today than it
was in the early 1980s when one in10,000 children were afflicted.
Today, the National Institutes of Health(NIH) estimates that one in 250
children are diagnosed as autistic.
Treatingthese children costs more than $60,000 per child, per year, according
toparents whose children have the disorder.
The number of children with ADD andADHD disorder also has increased
dramatically in the past two decades, withestimates topping two million,
according to the NIH. "Autism has migrated from a rare disorder to one that is
now 10 to 20times more likely to be diagnosed.
It's scientifically impossible for anepidemic to be caused by developmental,
genetic or 'brain damaged'conditions," said Dr. Goldberg.
"Without a doubt, this is a disease processmasquerading, or being
misinterpreted, as a 'developmental' disorder.
We needto stop assuming that the symptoms are a result of birth or genetic
defects orpsychological problems and start looking at the immune
connection."According to Dr.
Goldberg, NIDS patients are genetically predisposed tohaving a dysregulated
immune system.
The immune system malfunction can betriggered by a variety of factors.
Diagnosis for NIDS is simple: an immune panel run through blood testingand a
NeuroSPECT scan which measures blood flow to the brain.
NeuroSPECTscans of children with NIDS show reduced blood flow to portions of
the brain.By regulating and cooling down the immune system and the targeted use
ofFDA approved drugs, Dr. Goldberg and other specialists working with
thesechildren have seen dramatic improvements.Extensive clinical work over the
past five years supports the NIDS-RIhypothesis that many developmental disorders
are actually immune-mediateddiseases affecting the central nervous system. Dr.
Goldberg and Jeffrey Galpin, M.D., a clinical associate professor ofmedicine at
the University of Southern California and a renowned AIDS researcher, along with
the NIDS Scientific Advisory Board of leading medicalresearchers, professionals
and specialists from various fields are calling forthe trials of new immune
modulator drugs to be applied to adults and childrenwith these disorders in an
accelerated, expedient manner. For more information on NIDS, visit
A few weeks ago I asked everyone about the GF/CF diet and I thank you for the
many helpful responses. Has anyone experienced bed wetting as a side affect? He
doesn't normally do it & suddenly it is an issue. lhmirda@earthlink.net
******
NIMH is pleased to announce that Dr. Audrey Thurm is joining the extramural
staff of as a Program Specialist in the Division of Neuroscience and Basic
Behavioral Science. She will be working mostly on issues related to autism that
extend across the interagency, NIH, and NIMH levels. Major responsibilities
include activities of the Interagency Autism Coordinating Committee, and will
also have program responsibilities relevant to the new STAART Centers Program
and the overall NIMH autism portfolio. Dr. Thurm has worked on studies of
siblings of children diagnosed with autism spectrum disorders. Alison W. Bennett
ab43b@nih.gov
******
The Center For Developmental Excellence, LLC has moved! As of August 1, 2002,
our new office will be located at 113 West White Horse Rd Kirkwood Plaza, Suite
#5, Voorhees, NJ 08043. Our phone the same 856-778-1653. Many different
therapies and services available for Autism and Developmental
Music Therapy, Deep Pressure Massage, A DAN Doctor, The Listening Program and
more.
******
"National Missing Persons Week" occurs from August 4-10, 2002. Each year over
30,000 people go missing in Australia - that's one person every 17.5 minutes.
Police cannot single-handedly find all people lost, missing, abducted, or
wanted. The Missing Persons Register (TMPR) <
http://www.personsmissing.org>
helps close the gap. Additionally information is available about adoptions,
genealogy and reunions. TMPR is a FREE Community Service sponsored by The
Personals Network.
******
I am conducting a research study, funded by the borough of Barnet, into the
effects of diet intervention and different behavioural intervention programmes,
in the treatment of autism and related disorders. I would be very grateful if
you could supply me with ANY relevant journal articles, a selection of the
authors I am trying to find are: Reichelt, Knivsberg, Cade, Lucarelli, David
Mascaral, Ted Kniker, E. Sponheim, Naturally, I would cover all copying and
postage costs. Many thanks, Cheryl Ostryn [chezzie77@yahoo.com]
******
Talk Autism's next Specialty Chat Tuesday, July 23rd -- Finding Resources
Where You Live -- an Unlocking Autism State Rep's Tips - Gary Weitzen Join Gary
Weitzen (Unlocking Autism) by logging onto
Hello from Halifax, NS, Canada, I am looking for recent information on
working with young children with autistic spectrum disorder as part of
"interagency collaborative" efforts to provide a comprehensive continuum of
services for children with asd and their families. I know you have a wider
communications network and a wide search base than I would have through the
university data search engines so I would appreciate any help that you could
provide. Are there similar initiatives happening around the continent? Janice
Keddy, Early Identification and Intervention Services Central Region of Nova
Scotia jkeddy@Staff.Ednet.NS.Ca
******
>> FREE (Almost) READERS' POSTS <<
For Individuals, organizations, non-commercial and
commercial. Limit your posting to no more than 60
words please. There is no charge for this service,
but posters are obligated to thank all those who take
the time to answer your ads. This is a consideration
for others with autism after you and yours, who seek
assistance from appreciated readers. Send submissions to:
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"